上睑下垂
肿瘤微环境
免疫疗法
癌症免疫疗法
医学
癌症
癌症研究
免疫系统
免疫学
炎症
内科学
炎症体
作者
Zhi‐Jun Sun,Wen-Da Wang
出处
期刊:
[Elsevier BV]
日期:2022-03-01
卷期号:1 (1): 9130001-9130001
被引量:36
标识
DOI:10.26599/ntm.2022.9130001
摘要
Cancer immunotherapy, including immune checkpoint blockade, has emerged as a powerful and effective clinical strategy for the treatment of tumors. However, the low response rates or systemic adverse effects owing to the heterogeneity of the tumor microenvironment limit the efficacy of cancer immunotherapy. Pyroptosis, featuring inflammation and lysis, can promote the release of large amounts of proinflammatory agents that reprogram the tumor microenvironment and is expected to achieve the transition from "cold" tumors to "hot" tumors. Therefore, understanding how to particularly evoke tumor cell pyroptosis is crucial in overcoming the adverse effects associated with the tumor microenvironment. The development of emerging nanotechnology offers an avenue for tumor-targeted drug development. Nanomaterials that can trigger tumor-specific pyroptosis have promising applications in improving the efficacy of cancer immunotherapy while reducing systemic adverse effects. Herein, we review the fundamentals of pyroptosis, and summarize the strategies of pyroptosis-based nanomaterials that have been developed recently, with emphasis on their utility and benefits in cancer immunotherapy. Furthermore, we put forth our viewpoints regarding the investigation of nanomaterials and suggest future directions for this rapidly developing field.
科研通智能强力驱动
Strongly Powered by AbleSci AI